An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, Malawi

CompletedOBSERVATIONAL
Enrollment

3,507

Participants

Timeline

Start Date

July 21, 2019

Primary Completion Date

February 16, 2024

Study Completion Date

February 16, 2024

Conditions
13-valent Pneumococcal VaccineStreptococcus Pneumoniae
Interventions
OTHER

nasopharyngeal swab

A nasopharyngeal swab will be collected from consenting individuals by inserting a commercially-available dacron swab to the nasopharynx, gently rotating before removing.

Trial Locations (1)

P.O. Box 30096

Malawi-Liverpool-Wellcome Research Programme, Blantyre

All Listed Sponsors
collaborator

Malawi-Liverpool-Wellcome Trust Clinical Research Programme

OTHER

collaborator

Ministry of Health, Malawi

OTHER_GOV

collaborator

Blantyre District Health Office

UNKNOWN

collaborator

UNICEF

OTHER

collaborator

World Health Organization

OTHER

collaborator

University College, London

OTHER

collaborator

Liverpool School of Tropical Medicine

OTHER

lead

University of Liverpool

OTHER

NCT04078997 - An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, Malawi | Biotech Hunter | Biotech Hunter